Itrifal Shahtara for Eczema (Nar Farsi): A Comprehensive Review of Phytochemistry, Mechanisms, and Therapeutic Relevance
Abstract
Background: Eczema (Nar Farsi) is a chronic inflammatory skin disorder marked by pruritus, immune dysregulation, and epidermal barrier dysfunction, significantly affecting quality of life. Long-term use of conventional therapies such as corticosteroids and immune-suppressants is often limited by adverse effects. Unani medicine offers several time-tested polyherbal formulations for chronic skin diseases, among which Itrifal Shahtara is traditionally prescribed for pruritic and inflammatory dermatoses.
Objective: To evaluate the therapeutic relevance of Itrifal Shahtara in eczema by correlating its phytochemical constituents with known disease mechanisms.
Methods: A narrative review was conducted using electronic databases (PubMed, Google Scholar, ScienceDirect, Elsevier, ResearchGate) and classical Unani literature. Experimental studies, clinical reports, and pharmacological evidence related to the formulation’s constituents were analyzed.
Results: The constituents of Itrifal Shahtara exhibit anti-inflammatory, immunomodulatory, antioxidant, anti-pruritic, antimicrobial, and skin barrier–supportive activities. These effects are mediated through modulation of cytokine pathways, reduction of oxidative stress, suppression of inflammatory mediators, and improvement of epidermal integrity.
Discussion and Conclusion: The multi-targeted pharmacological actions of Itrifal Shahtara align with both Unani principles and contemporary understanding of eczema pathogenesis, supporting its potential role as a safer long-term therapeutic option. However, rigorously designed clinical trials are required to validate its efficacy, safety, and standardization
Keywords: Eczema; Nar Farsi; Itrifal Shahtara; Unani medicine; Phytochemistry; Anti-inflammatory agents
Keywords:
Eczema, Nar Farsi, Itrifal Shahtara, Unani medicine, Phytochemistry, Anti-inflammatory agentsDOI
https://doi.org/10.22270/jddt.v16i2.7556References
1. Mohajerani F, Hajimahmoodi M, Shirbeigi L, Rahimi R. Medicinal plants as a source of future anti-pruritic drugs: A comprehensive review. Bol Latinoam Caribe Plant Med Aromat. 2019;18(1):1-15. https://doi.org/10.35588/blacpma.19.18.1.01
2. Zaki MK, et al. [Title of article]. IJPPR Human. 2021;23(1):11-20.
3. Roxburgh RM, editor. Roxburgh's Common Skin Diseases. 17th ed. London: Hodder Arnold; 2003. p.105-114.
4. Kabiruddin. Tarjuma-e-Kabeer (Urdu translation of Sharah Asbab wa Alamat). Hyderabad: Hikmat Book Depot; YNM. p.256-257.
5. Jurjani AH. Zakheera Khwarzam Shahi. 4th ed. Lucknow: Munshi Nawal Kishore; 1903. Vol 3. p.18.
6. Kabeeruddin HM. Bayaz-e-Kabir Kamil. Part 2. New Delhi: Maktaba Al-Shifa; 2018. p.307-308.
7. Tabri AM. Moalajat Buqratiyah (Urdu translation). Vol 2. New Delhi: CCRUM; 1997. p.252-253.
8. Sina I. Al-Qanoon Fil Tibb. Urdu translation by Kanturi GH. New Delhi: Idara Kitab-us-Shifa, Daryaganj; 2010. p.1260-1261.
9. Arora P, Bhatia S, Garg M, Kumari S, Goyal A. Curative potency of medicinal plants in management of eczema: A conservative approach. Phytomedicine Plus. 2022;2(2):100256. https://doi.org/10.1016/j.phyplu.2022.100256
10. Tierney LM, Papadakis MA, McPhee SJ. Current Medical Diagnosis and Treatment. New York: McGraw-Hill; 2005. p.84-144.
11. Alam MM, Ussalam M, Goswami A, Alam MI, Ahmad M, Rajesh, Imam MH, Bano S. A clinical study on Itrifal Shahatra and Sharbat Unnab to evaluate the mechanisms of action and Unani principles in Buthūr (Acne). Res Rev J Unani Siddha Homeopath. 2022;9(3):9-16.
12. Kabeeruddin AM. Makhzan-ul-Mufradat. New Delhi: Idara Kitab-ul-Shifa; 2014. p.279.
13. Iraji F, Sharif Makhmalzadeh B, Abedini M, Aghaei A, Siahpoush A. Effect of herbal cream containing Fumaria officinalis and silymarin for treatment of eczema: A randomized double-blind controlled clinical trial. Avicenna J Phytomed. 2022;12(2):155-162.
14. Anonymous. Fumaria officinalis (Fumitory): The Western Herbal Tradition. London: Elsevier Ltd; 2009. p.165.
15. Kabeeruddin AM. Makhzan-ul-Mufradat. New Delhi: Idara Kitab-ul-Shifa; 2014. p.415.
16. Kim HJ, Song HK, Park SH, Jang S, Park KS, Song KH, Lee SK, Kim T. Terminalia chebula Retz. extract ameliorates symptoms of atopic dermatitis by regulating anti-inflammatory factors in vivo and suppressing STAT1/3 and NF-κB signaling in vitro. Phytomedicine. 2022;104:154318. https://doi.org/10.1016/j.phymed.2022.154318 PMid:35830757
17. Khan A, Siddiqui A, Jafri MA, Asif M, Chaudhary SS. Review of Halela Siyah with Unani perspective and modern pharmacology. World J Pharm Res. 2018;7(9):1-15.
18. Kabeeruddin AM. Makhzan-ul-Mufradat. New Delhi: Idara Kitab-ul-Shifa; 2014. p.416.
19. Gupta A, Kumar R, Bhattacharyya P, Bishayee A, Pandey AK. Terminalia bellirica (Gaertn.) Roxb. (Bahera) in health and disease: A systematic and comprehensive review. Phytomedicine. 2020;76:153278. https://doi.org/10.1016/j.phymed.2020.153278 PMid:32781393
20. Kumar N, Khurana SMP. Phytochemistry and medicinal potential of Terminalia bellirica Roxb. (Bahera). Indian J Nat Prod Resour. 2018;9:97-107.
21. Kabeeruddin AM. Makhzan-ul-Mufradat. New Delhi: Idara Kitab-ul-Shifa; 2014. p.49.
22. Kunchana K, Jarisarapurin W, Chularojmontri L, Wattanapitayakul SK. Potential use of Amla (Phyllanthus emblica L.) fruit extract to protect skin keratinocytes from inflammation and apoptosis after UVB irradiation. Antioxidants. 2021;10:703. https://doi.org/10.3390/antiox10050703 PMid:33946757 PMCid:PMC8146754
23. Kabeeruddin AM. Makhzan-ul-Mufradat. New Delhi: Idara Kitab-ul-Shifa; 2014. p.264.
24. Ikram A, Khalid W, Saeed F, Arshad MS, Afzaal M, Arshad MU. Senna: As immunity-boosting herb against COVID-19 and several other diseases. J Herb Med. 2023;37:100626. https://doi.org/10.1016/j.hermed.2023.100626 PMid:36644449 PMCid:PMC9830937
25. Chew YL, Khor MA, Xu Z, Lee SK, Keng JW, Sang SH, Akowuah GA, Goh KW, Liew KB, Ming LC. Cassia alata, Coriandrum sativum, Curcuma longa and Azadirachta indica: Food ingredients as complementary and alternative therapies for atopic dermatitis-A comprehensive review. [Journal name required].
26. Kabeeruddin AM. Makhzan-ul-Mufradat. New Delhi: Idara Kitab-ul-Shifa; 2014. p.350.
27. Wang Y, Zhao Y, Liu X, Li J, Zhang J, Liu D. Chemical constituents and pharmacological activities of medicinal plants from Rosa genus. Chin Herb Med. 2022;14(2):187-209. https://doi.org/10.1016/j.chmed.2022.01.005 PMid:36117670 PMCid:PMC9476647
28. Kabeeruddin AM. Makhzan-ul-Mufradat. New Delhi: Idara Kitab-ul-Shifa; 2014. p.396.
29. Kumar A, Sharma A, Pragi, Kumar V. [Title of article]. Int J Pharm Sci Res. 2023;14(6):2670-2677.
30. Singh CK, Mintie CA, Ndiaye MA, Chhabra G, Roy S, Sullivan R, Longley BJ, Schieke SM, Ahmad N. Protective effects of dietary grape against atopic dermatitis-like skin lesions in NC/NgaTndCrlj mice. Front Immunol. 2023;13:1051472. https://doi.org/10.3389/fimmu.2022.1051472 PMid:36741360 PMCid:PMC9893861
31. Hasan M, Zanjabil K, Ara I, Rahman T, Kieu A, Östlundh L, Junaidi S, Khan M. Herbal therapies for pain management: A scoping review of the current evidence. Phytochem Rev. 2024;1-52. https://doi.org/10.1007/s11101-024-09916-0
Published
Abstract Display: 333 
PDF Downloads: 134 PDF Downloads: 74 How to Cite
Issue
Section
Copyright (c) 2026 Madiha Akhtar , Munawwar Gauri , S.M. Abbas Zaidi , Mohammad Anzar Husain , Saima Sharfuddin
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.